Article
Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.
The Journal of general physiology - 1 Jan 2013
de Lange Willem J, Grimes Adrian C, Hegge Laura F, Ralphe J Carter
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) caused by mutations in cardiac myosin-binding protein-C (cMyBP-C) is a heterogenous disease in which the phenotypic presentation is influenced by genetic, environmental, and developmental factors. Though mouse models have been used extensively to study the contractile effects of cMyBP-C ablation, early postnatal hypertrophic and dilatory remodeling may overshadow primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
